Articles from Biotech Business (March 1, 2000)

Title	Author	Type	Words
ATRIX PROVES EFFECTIVENESS OF DRUG DELIVERY TECHNOLOGY.		Brief Article	697
ATRIX REPORTS SUCCESSFUL RESULTS FOR PROSTATE CANCER TREATMENT.		Brief Article	448
AVI BIOPHARMA STARTS DEVELOPMENT OF TWO CANCER ANTIBODIES.		Brief Article	371
CURAGEN GETS PATENTS ON INTERACTIONS IMPLICATED IN CANCER.		Brief Article	430
EMISPHERE FILES IND FOR CLINICAL TESTING OF HEPARIN TABLETS.			540
FDA ACCEPTS IMPAX ANDA FOR GENERIC VERSION OF CLARITIN-D.			372
NIH AWARDS $1.5 MILLION ANTIFUNGAL GRANT TO UNC-CHAPEL HILL.			533
SCIOS TO BEGIN PHASE IB MULTI-DOSE TRIAL OF SCIO-469.			451
TARGETED GENETICS GETS GENE THERAPY PATENT FOR CHOLESTEROL.			571
TRIMERIS/HOFFMAN LA ROCHE PROGRESS WITH HIV FUSION INHIBITORS.		Brief Article	896